메뉴 건너뛰기




Volumn 110, Issue 2, 2016, Pages 268-278

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE-and LDLR-mediated mechanisms

Author keywords

Atherosclerosis; Hepatocytes; Lipoproteins; Murine models; PCSK9

Indexed keywords

APOLIPOPROTEIN E; LIGAND; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SERINE PROTEINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LOW DENSITY LIPOPROTEIN RECEPTOR; PCSK9 PROTEIN, HUMAN; PCSK9 PROTEIN, MOUSE; PROPROTEIN CONVERTASE 9;

EID: 84966587947     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw053     Document Type: Article
Times cited : (91)

References (62)
  • 1
    • 34547108600 scopus 로고    scopus 로고
    • Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation
    • Zhang DW, Lagace TA, Garuti R, Zhao Z, McDonald M, Horton JD, Cohen JC, Hobbs HH. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem 2007;282:18602-18612.
    • (2007) J Biol Chem , vol.282 , pp. 18602-18612
    • Zhang, D.W.1    Lagace, T.A.2    Garuti, R.3    Zhao, Z.4    McDonald, M.5    Horton, J.D.6    Cohen, J.C.7    Hobbs, H.H.8
  • 2
    • 13844310887 scopus 로고    scopus 로고
    • Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment
    • Maxwell KN, Fisher EA, Breslow JL. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci USA 2005;102:2069-2074.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 2069-2074
    • Maxwell, K.N.1    Fisher, E.A.2    Breslow, J.L.3
  • 3
    • 33750090075 scopus 로고    scopus 로고
    • The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: Functional consequences of natural mutations and post-translational modifications
    • Benjannet S, Rhainds D, Hamelin J, Nassoury N, Seidah NG. The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications. J Biol Chem 2006;281:30561-30572.
    • (2006) J Biol Chem , vol.281 , pp. 30561-30572
    • Benjannet, S.1    Rhainds, D.2    Hamelin, J.3    Nassoury, N.4    Seidah, N.G.5
  • 4
    • 84897889156 scopus 로고    scopus 로고
    • PCSK9: A key modulator of cardiovascular health
    • Seidah NG, Awan Z, Chretien M, Mbikay M. PCSK9: a key modulator of cardiovascular health. Circ Res 2014;114:1022-1036.
    • (2014) Circ Res , vol.114 , pp. 1022-1036
    • Seidah, N.G.1    Awan, Z.2    Chretien, M.3    Mbikay, M.4
  • 5
    • 84921262461 scopus 로고    scopus 로고
    • On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects
    • Tavori H, Rashid S, Fazio S. On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects. Atherosclerosis 2015;238:264-270.
    • (2015) Atherosclerosis , vol.238 , pp. 264-270
    • Tavori, H.1    Rashid, S.2    Fazio, S.3
  • 6
    • 2442670243 scopus 로고    scopus 로고
    • Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia
    • Leren TP. Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia. Clin Genet 2004;65:419-422.
    • (2004) Clin Genet , vol.65 , pp. 419-422
    • Leren, T.P.1
  • 8
    • 84918815314 scopus 로고    scopus 로고
    • PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: A cross-sectional cohort study
    • Saavedra YG, Dufour R, Davignon J, Baass A. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study. Arterioscler Thromb Vasc Biol 2014;34:2700-2705.
    • (2014) Arterioscler Thromb Vasc Biol , vol.34 , pp. 2700-2705
    • Saavedra, Y.G.1    Dufour, R.2    Davignon, J.3    Baass, A.4
  • 9
    • 33645103550 scopus 로고    scopus 로고
    • Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
    • Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354: 1264-1272.
    • (2006) N Engl J Med , vol.354 , pp. 1264-1272
    • Cohen, J.C.1    Boerwinkle, E.2    Mosley, Jr.T.H.3    Hobbs, H.H.4
  • 21
    • 84879287631 scopus 로고    scopus 로고
    • Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: Evidence for a reciprocal regulation
    • Tavori H, Fan D, Blakemore JL, Yancey PG, Ding L, Linton MF, Fazio S. Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation. Circulation 2013;127:2403-2413.
    • (2013) Circulation , vol.127 , pp. 2403-2413
    • Tavori, H.1    Fan, D.2    Blakemore, J.L.3    Yancey, P.G.4    Ding, L.5    Linton, M.F.6    Fazio, S.7
  • 25
    • 84879315149 scopus 로고    scopus 로고
    • Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to highdose statin therapy
    • Raal F, Panz V, Immelman A, Pilcher G. Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to highdose statin therapy. J Am Heart Assoc 2013;2:e000028.
    • (2013) J Am Heart Assoc , vol.2 , pp. e000028
    • Raal, F.1    Panz, V.2    Immelman, A.3    Pilcher, G.4
  • 26
    • 84905101303 scopus 로고    scopus 로고
    • Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptordependent and-independent mechanisms
    • Rashid S, Tavori H, Brown PE, Linton MF, He J, Giunzioni I, Fazio S. Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptordependent and-independent mechanisms. Circulation 2014;130:431-441.
    • (2014) Circulation , vol.130 , pp. 431-441
    • Rashid, S.1    Tavori, H.2    Brown, P.E.3    Linton, M.F.4    He, J.5    Giunzioni, I.6    Fazio, S.7
  • 27
    • 84907494683 scopus 로고    scopus 로고
    • Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice
    • Tavori H, Fan D, Giunzioni I, Zhu L, Linton MF, Fogo AB, Fazio S. Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice. J Lipid Res 2014;55:2073-2081.
    • (2014) J Lipid Res , vol.55 , pp. 2073-2081
    • Tavori, H.1    Fan, D.2    Giunzioni, I.3    Zhu, L.4    Linton, M.F.5    Fogo, A.B.6    Fazio, S.7
  • 29
    • 84900342583 scopus 로고    scopus 로고
    • Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins
    • Kwakernaak AJ, Lambert G, Dullaart RP. Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins. Clin Biochem 2014; 47:679-682.
    • (2014) Clin Biochem , vol.47 , pp. 679-682
    • Kwakernaak, A.J.1    Lambert, G.2    Dullaart, R.P.3
  • 30
    • 80054696614 scopus 로고    scopus 로고
    • Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people
    • SulliVan S, Fabbrini E, Horton JD, Korenblat K, Patterson BW, Klein S. Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people. Transl Res 2011;158:302-306.
    • (2011) Transl Res , vol.158 , pp. 302-306
    • Van S, S.1    Fabbrini, E.2    Horton, J.D.3    Korenblat, K.4    Patterson, B.W.5    Klein, S.6
  • 32
    • 45549096592 scopus 로고    scopus 로고
    • Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB
    • Blasiole DA, Oler AT, Attie AD. Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB. J Biol Chemistry 2008;283:11374-11381.
    • (2008) J Biol Chemistry , vol.283 , pp. 11374-11381
    • Blasiole, D.A.1    Oler, A.T.2    Attie, A.D.3
  • 33
    • 33748752232 scopus 로고    scopus 로고
    • Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: Lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor
    • Lambert G, Jarnoux AL, Pineau T, Pape O, Chetiveaux M, Laboisse C, Krempf M, Costet P. Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. Endocrinology 2006;147:4985-4995.
    • (2006) Endocrinology , vol.147 , pp. 4985-4995
    • Lambert, G.1    Jarnoux, A.L.2    Pineau, T.3    Pape, O.4    Chetiveaux, M.5    Laboisse, C.6    Krempf, M.7    Costet, P.8
  • 36
    • 33845970192 scopus 로고    scopus 로고
    • Ly-6 Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
    • Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ. Ly-6 Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007;117:195-205.
    • (2007) J Clin Invest , vol.117 , pp. 195-205
    • Swirski, F.K.1    Libby, P.2    Aikawa, E.3    Alcaide, P.4    Luscinskas, F.W.5    Weissleder, R.6    Pittet, M.J.7
  • 37
    • 84886797808 scopus 로고    scopus 로고
    • Macrophages in atherosclerosis: A dynamic balance
    • Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013;13:709-721.
    • (2013) Nat Rev Immunol , vol.13 , pp. 709-721
    • Moore, K.J.1    Sheedy, F.J.2    Fisher, E.A.3
  • 38
    • 84933277172 scopus 로고    scopus 로고
    • Proprotein convertase subtilisin/kexin 9 concentrations correlate with coronary artery disease atheroma burden in a Pakistani cohort with chronic chest pain
    • Walton TA, Nishtar S, Lumb PJ, Crook MA, Marber MS, Gill J, Wierzbicki AS. Proprotein convertase subtilisin/kexin 9 concentrations correlate with coronary artery disease atheroma burden in a Pakistani cohort with chronic chest pain. Int J Clin Pract 2015.
    • (2015) Int J Clin Pract
    • Walton, T.A.1    Nishtar, S.2    Lumb, P.J.3    Crook, M.A.4    Marber, M.S.5    Gill, J.6    Wierzbicki, A.S.7
  • 41
    • 84900854191 scopus 로고    scopus 로고
    • Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
    • Li S, Guo YL, Xu RX, Zhang Y, Zhu CG, Sun J, Qing P, Wu NQ, Jiang LX, Li JJ. Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease. Atherosclerosis 2014;234:441-445.
    • (2014) Atherosclerosis , vol.234 , pp. 441-445
    • Li, S.1    Guo, Y.L.2    Xu, R.X.3    Zhang, Y.4    Zhu, C.G.5    Sun, J.6    Qing, P.7    Wu, N.Q.8    Jiang, L.X.9    Li, J.J.10
  • 42
    • 84866499818 scopus 로고    scopus 로고
    • PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-kappaB activation in THP-1-derived macrophages
    • Tang Z, Jiang L, Peng J, Ren Z, Wei D, Wu C, Pan L, Jiang Z, Liu L. PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-kappaB activation in THP-1-derived macrophages. Int J Mol Med 2012;30:931-938.
    • (2012) Int J Mol Med , vol.30 , pp. 931-938
    • Tang, Z.1    Jiang, L.2    Peng, J.3    Ren, Z.4    Wei, D.5    Wu, C.6    Pan, L.7    Jiang, Z.8    Liu, L.9
  • 46
    • 84901365380 scopus 로고    scopus 로고
    • Hepatic overexpression of Idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: Sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways
    • Sasaki M, Terao Y, Ayaori M, Uto-Kondo H, Iizuka M, Yogo M, Hagisawa K, Takiguchi S, Yakushiji E, Nakaya K, Ogura M, Komatsu T, Ikewaki K. Hepatic overexpression of Idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways. Arterioscler Thromb Vasc Biol 2014;34:1171-1178.
    • (2014) Arterioscler Thromb Vasc Biol , vol.34 , pp. 1171-1178
    • Sasaki, M.1    Terao, Y.2    Ayaori, M.3    Uto-Kondo, H.4    Iizuka, M.5    Yogo, M.6    Hagisawa, K.7    Takiguchi, S.8    Yakushiji, E.9    Nakaya, K.10    Ogura, M.11    Komatsu, T.12    Ikewaki, K.13
  • 47
    • 84907140899 scopus 로고    scopus 로고
    • AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia
    • Somanathan S, Jacobs F, Wang Q, Hanlon AL, Wilson JM, Rader DJ. AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia. Circ Res 2014;115:591-599.
    • (2014) Circ Res , vol.115 , pp. 591-599
    • Somanathan, S.1    Jacobs, F.2    Wang, Q.3    Hanlon, A.L.4    Wilson, J.M.5    Rader, D.J.6
  • 48
    • 24344454636 scopus 로고    scopus 로고
    • Physiological releVance of apolipoprotein e recycling: Studies in primary mouse hepatocytes
    • Zhu MY, Hasty AH, Harris C, Linton MF, Fazio S, Swift LL. Physiological releVance of apolipoprotein E recycling: studies in primary mouse hepatocytes. Metabolism 2005; 54:1309-1315.
    • (2005) Metabolism , vol.54 , pp. 1309-1315
    • Zhu, M.Y.1    Hasty, A.H.2    Harris, C.3    Linton, M.F.4    Fazio, S.5    Swift, L.L.6
  • 49
    • 0038322016 scopus 로고    scopus 로고
    • The recycling of apolipoprotein e in primary cultures of mouse hepatocytes. Evidence for a physiologic connection to high density lipoprotein metabolism
    • Farkas MH, Swift LL, Hasty AH, Linton MF, Fazio S. The recycling of apolipoprotein E in primary cultures of mouse hepatocytes. Evidence for a physiologic connection to high density lipoprotein metabolism. J Biol Chem 2003;278:9412-9417.
    • (2003) J Biol Chem , vol.278 , pp. 9412-9417
    • Farkas, M.H.1    Swift, L.L.2    Hasty, A.H.3    Linton, M.F.4    Fazio, S.5
  • 51
    • 0030042092 scopus 로고    scopus 로고
    • Hepatic insulin resistance after pancreas transplantation in type i diabetes
    • Rooney DP, Robertson RP. Hepatic insulin resistance after pancreas transplantation in type I diabetes. Diabetes 1996;45:134-138.
    • (1996) Diabetes , vol.45 , pp. 134-138
    • Rooney, D.P.1    Robertson, R.P.2
  • 52
    • 84890425649 scopus 로고    scopus 로고
    • Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis
    • Tavori H, Giunzioni I, Linton MF, Fazio S. Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis. Circ Res 2013;113:1290-1295.
    • (2013) Circ Res , vol.113 , pp. 1290-1295
    • Tavori, H.1    Giunzioni, I.2    Linton, M.F.3    Fazio, S.4
  • 53
    • 84921459685 scopus 로고    scopus 로고
    • Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): A randomised, double-blind, placebocontrolled trial
    • TESLA Investigators
    • Raal FJ, Honarpour N, Blom DJ, Hovingh GK, Xu F, Scott R,Wasserman SM, Stein EA, TESLA Investigators. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebocontrolled trial. Lancet 2015;385:341-350.
    • (2015) Lancet , vol.385 , pp. 341-350
    • Raal, F.J.1    Honarpour, N.2    Blom, D.J.3    Hovingh, G.K.4    Xu, F.5    Scott Rwasserman, S.M.6    Stein, E.A.7
  • 54
    • 0028268018 scopus 로고
    • The two-receptor model of lipoprotein clearance: Tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins
    • Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994; 91:4431-4435.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 4431-4435
    • Ishibashi, S.1    Herz, J.2    Maeda, N.3    Goldstein, J.L.4    Brown, M.S.5
  • 57
    • 0033516647 scopus 로고    scopus 로고
    • A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation
    • Linton MF, Babaev VR, Gleaves LA, Fazio S. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J Biol Chem 1999;274: 19204-19210.
    • (1999) J Biol Chem , vol.274 , pp. 19204-19210
    • Linton, M.F.1    Babaev, V.R.2    Gleaves, L.A.3    Fazio, S.4
  • 58
    • 84877675332 scopus 로고    scopus 로고
    • Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)
    • Canuel M, Sun X, Asselin MC, Paramithiotis E, Prat A, Seidah NG. Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1). PLoS One 2013;8:e64145.
    • (2013) PLoS One , vol.8 , pp. e64145
    • Canuel, M.1    Sun, X.2    Asselin, M.C.3    Paramithiotis, E.4    Prat, A.5    Seidah, N.G.6
  • 59
    • 33947715605 scopus 로고    scopus 로고
    • Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse
    • Overton CD, Yancey PG, Major AS, Linton MF, Fazio S. Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ Res 2007;100: 670-677.
    • (2007) Circ Res , vol.100 , pp. 670-677
    • Overton, C.D.1    Yancey, P.G.2    Major, A.S.3    Linton, M.F.4    Fazio, S.5
  • 60
    • 33646458863 scopus 로고    scopus 로고
    • Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines
    • Ruan XZ, Moorhead JF, Tao JL, Ma KL, Wheeler DC, Powis SH, Varghese Z. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 2006; 26:1150-1155.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 1150-1155
    • Ruan, X.Z.1    Moorhead, J.F.2    Tao, J.L.3    Ma, K.L.4    Wheeler, D.C.5    Powis, S.H.6    Varghese, Z.7
  • 61
    • 84887863897 scopus 로고    scopus 로고
    • Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation
    • Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, Lv LL, Ruan XZ, Liu BC. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovasc Res 2013;100:450-460.
    • (2013) Cardiovasc Res , vol.100 , pp. 450-460
    • Ma, K.L.1    Liu, J.2    Wang, C.X.3    Ni, J.4    Zhang, Y.5    Wu, Y.6    Lv, L.L.7    Ruan, X.Z.8    Liu, B.C.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.